fda warning letter glp-1 october 2025 warns Novo Nordisk over medication side effects FDA Issues 30 Warning Letters

It is about being honest with your health, your medication routine, and your responsibilities

Common signs of NAION include: Sudden, unilateral painless loss of vision Visual field defect (usually altitudinal) Blurred vision Dyschromatopsia (new onset impairment or loss of color vision) Relative afferent pupillary defect Optic disc swelling with or without hemorrhages A patient starting a GLP-1RAespecially if they have diabetes or age-related macular degeneration should have an in-person, comprehensive, dilated eye examination either within the 12 months prior to starting therapy or a baseline examination within one month of initiating therapy

Prime Therapeutics

You may also feel bloated but unable to pass gas or stool